Does HUMALOG LISPRO, NPL Cause Dyspnoea? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Dyspnoea have been filed in association with HUMALOG LISPRO, NPL. This represents 7.3% of all adverse event reports for HUMALOG LISPRO, NPL.
8
Reports of Dyspnoea with HUMALOG LISPRO, NPL
7.3%
of all HUMALOG LISPRO, NPL reports
1
Deaths
5
Hospitalizations
How Dangerous Is Dyspnoea From HUMALOG LISPRO, NPL?
Of the 8 reports, 1 (12.5%) resulted in death, 5 (62.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMALOG LISPRO, NPL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does HUMALOG LISPRO, NPL Cause?
Blood glucose increased (26)
Hypoglycaemia (9)
Incorrect dose administered (8)
Malaise (8)
Visual impairment (8)
Wrong drug administered (8)
Blood glucose decreased (7)
Drug dose omission (7)
Maternal exposure during pregnancy (7)
Fall (6)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which HUMALOG LISPRO, NPL Alternatives Have Lower Dyspnoea Risk?
HUMALOG LISPRO, NPL vs HUMAN C1-ESTERASE INHIBITOR
HUMALOG LISPRO, NPL vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
HUMALOG LISPRO, NPL vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
HUMALOG LISPRO, NPL vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
HUMALOG LISPRO, NPL vs HUMAN IMMUNOGLOBULIN G